Enter the first few characters of Company and click 'Go'
Annual Financial Results of Beryl Drugs Ltd.(Figures in Rs crores)
|
|
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Net Sales / Income |
26.89 |
14.60 |
14.09 |
13.05 |
13.20 |
Other Income |
0.27 |
0.16 |
0.19 |
0 |
0 |
Net Profit/Loss |
0.77 |
-0.66 |
0.24 |
0.05 |
0.59 |
Raw Material |
14.23 |
8.71 |
7.45 |
6.68 |
6.85 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
1.70 |
1.31 |
1.18 |
0.97 |
0.85 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
8.71 |
4.48 |
4.05 |
4.34 |
4.11 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.42 |
0.44 |
0.47 |
0.32 |
0.15 |
Gross Profit |
1.80 |
0.14 |
1.17 |
0.82 |
1.12 |
Depreciation |
0.81 |
1.09 |
1.27 |
0.66 |
0.32 |
Taxation |
0.22 |
-0.29 |
0.11 |
0.11 |
0.21 |
Extra Ordinary Item |
0 |
0 |
0.45 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
5.07 |
5.07 |
5.07 |
5.07 |
5.07 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
1.51 |
-1.30 |
0.47 |
0.09 |
1.16 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article